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Abstract
Inflammatory damage of mucosal surface of the eye is a hallmark of dry eye disease (DED), and 
in severe cases can lead to significant discomfort, visual impairment, and blindness. DED is a 
multifactorial autoimmune disorder with a largely unknown pathogenesis. Using a cross-sectional 
patient study and a well-characterized murine model of DED, herein we investigated the 
immunoregulatory function of interleukin-22 (IL-22) in the pathogenesis of DED. We found that 
IL-22 levels were elevated in lacrimal fluids of DED patients and inversely correlated with severity 
of disease. Acinar cells of the lacrimal glands, not inflammatory immune cells, are the primary 
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source of IL-22, which suppresses inflammation in ocular surface epithelial cells upon desiccating 
stress. Moreover, loss of function analyses using IL-22 knock-out mice demonstrated that IL-22 is 
essential for suppression of ocular surface infiltration of Th17 cells and inhibition of DED 
induction. Our novel findings elucidate immunoregulatory function of lacrimal gland-derived 
IL-22 in inhibiting IL-17-mediated ocular surface epitheliopathy in DED thus making IL-22 a new 
relevant therapeutic target.
INTRODUCTION
Ocular mucosal inflammation is characteristic for dry eye disease (DED),1, 2 a highly 
prevalent ocular surface autoimmune disorder. Uncontrolled severe DED can lead to vision 
loss due to inflammation-induced corneal ulceration and scaring.3, 4 In the progression of 
DED, pathogenic immune cells, predominantly Th17 cells continuously migrate to the 
ocular mucosal surface5–9 and secrete pro-inflammatory mediators, including interleukin 
(IL)-17,10, 11 IL-1,12 and tumor necrosis factor (TNF)-α13, 14 causing ocular surface 
inflammation and epitheliopathy. Despite strong evidence that Th17 cells are involved in 
ongoing DED inflammation, the precise pathological and regulatory mechanisms are not yet 
well understood.
IL-22, a member of the IL-10 superfamily, is a multifunction cytokine which is secreted by 
various immune cells such as Th17 and innate lymphoid cells during the course of mucosal 
immune response.15 Unlike other interleukins, IL-22 does not directly regulate the function 
of immune cells. Instead, it binds to the IL-22 receptor (IL-22R) on cells of the skin, 
pancreas, liver, kidney, and tissues of the digestive and respiratory systems.15–18 Serum 
levels of IL-22 have been shown to be significantly elevated in patients with Sjögren’s 
syndrome (SS), an autoimmune disorder causing dry eye and dry mouth conditions.19 Both 
protein and mRNA levels of IL-22, IL-23, and IL-17 have also been reported significantly 
high in the inflammatory salivary glands of SS patients.20 In addition, phosphorylation of 
signal transducer and activator of transcription 3 (STAT3), a specific transcriptional activator 
of IL-22 and IL-17 is up-regulated in the exocrine glands of SS patients21, 22 suggesting a 
functional association between IL-22 and IL-17 in the pathogenesis of SS. Recently, 
elevated levels of IL-22 have been shown in tears of patents with DED.11 Moreover, IL-22 
has been shown to promote epithelial wound healing.23 Despite multiple reports on 
expression of IL-22 in various eye conditions, the precise function of IL-22 in the 
immunopathogenesis of DED remains unknown.
In the present study, we have investigated the function and cellular source of IL-22 in the 
pathogenesis of DED. We found, for the first time, that the lacrimal gland secretes elevated 
levels of IL-22, which prevents ocular surface epitheliopathy and infiltration of pathogenic 
Th17 cells. Using IL-22 deficient mice we confirmed that IL-22 contributes to the inhibition 
of Th17-medited inflammation, and suppresses initiation and development of DED.
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RESULTS
Increased IL-22 levels in lacrimal fluids of patients with dry eye disease
DED pathogenesis is primarily associated with the infiltration of Th17 cells, which have 
been demonstrated to secrete IL-17 and IL-22.11, 16 Since tears are a mixed fluid composed 
of secretions from the lacrimal gland (LG), meibomian gland, and corneoconjunctival cells, 
we precisely collected the pure LG-secreted fluid (LF) and total tear fluid (TF) from 
conjunctival sac (Supplement 1, video file) of healthy controls and DED patients to evaluate 
the expression level of IL-22 and IL-17. IL-22 levels in LFs of DED patients (median 1621 
pg/ml; interquartile, IQR 1154 – 2641) were significantly higher as compared to the healthy 
control (median 51 pg/ml, IQR 25 – 99, p < 0.001; Fig 1A). However, no significant 
difference in the IL-22 levels was observed in TFs of DED patients (median 566 pg/ml, IQR 
421 – 811) and healthy controls (median 492 pg/ml, IQR 403 – 621). These increased levels 
of IL-22 in LFs but not TFs, suggest that LGs could be primary source of high levels of 
IL-22 in DED. IL-17 levels in LFs (median 769 pg/ml, IQR 421 – 1101) of DED patient 
were significantly higher as compared to healthy controls (median 27.5 pg/ml, IQR 19 – 45, 
p < 0.001; Fig. 1B). In contrast to IL-22, IL-17 levels in TFs of DED patients (median 
3289.5 pg/ml, IQR 2514 – 3688) were higher than in healthy controls (median 527 pg/ml, 
IQR 216 – 621, p < 0.001).
IL-22 levels inversely correlate with the severity of dry eye disease
Having shown the increased expression of IL-22 and IL-17 in the LFs of DED patients, we 
next determined the association of IL-22 and IL-17 levels with the severity of DED. 
Correlation and regression analyses were performed to determine correlation between 
cytokine levels and the severity of DED measured as ocular surface disease index (OSDI). 
Significant negative correlations between the levels of IL-22 both in LFs (r = −0.777, p < 
0.001) or TFs (r = −0.922, p < 0.001) and OSDI score were observed suggesting that IL-22 
at the ocular surface could be associated with reduction of disease severity (Fig 1C). In 
contrast to IL-22, significant positive correlations between the IL-17 levels both in LFs (r = 
0.869, p < 0.001) or TFs (r = 0.855, p < 0.001) and OSDI scores was observed indicating 
that IL-17 is involved in augmenting disease severity (Fig 1D). Moreover, OSDI scores 
below 20 were associated with undetectable levels of IL-17 in both LFs and TFs.
Lacrimal glands expressed high levels of IL-22 in a murine model of dry eye disease
Increased IL-22 expression particularly in LFs and its negative correlation with disease 
severity prompted us to examine the cellular source of IL-22 in DED. Since investigating the 
source of IL-22 in human LGs was not possible, we used a well standardized murine model 
of DED5–8 for further investigations. LGs from DED and healthy mice (control) were 
harvested. Real-time PCR was performed to measure IL-22 mRNA expression. Similar to 
our observation in DED patients, DED induction in mice resulted in a significant increase in 
IL-22 mRNA expression compared to control non DED mice (Fig 2A). IL-22 expression 
was further confirmed at protein level by performing ELISA on the supernatants from LG 
lysates. A significant 5 – 6 fold increase in IL-22 protein was observed in DED mice 
compared to control group (Fig 2B). Furthermore, we investigated the precise cellular source 
of IL-22 in the LG using immunohistochemistry. DED induction resulted in increased IL-22 
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expression and massive LG infiltration of leukocytes compared to control mice. But 
surprisingly, this increased IL-22 expression was associated primarily with the glandular 
acinar cells, and not infiltrating leukocytes (Fig 2C, D). These IL-22 positive acinar cells 
were in close proximity of infiltrating immune cells.
IL-22 receptor expression on the ocular surface
The fact that receptor expression at the site of action is essential for cytokines to exert their 
function led us to investigate the IL-22 receptor system at the ocular surface. IL-22 receptor 
is a heterodimer of IL-22R1 and IL-10R2 subunits. Real time PCR for IL-22R1 and IL10R2 
mRNA expression in total corneal and conjunctival lysates was performed. The results 
revealed that IL-22R1 is constitutively expressed at the ocular surface and its expression 
does not alter after DED induction. However, IL-10R2 expression was upregulated at the 
ocular surface in DED mice compared to control mice (Fig 3A). Similar to mRNA 
expression, protein expression analyses using flow cytometry and immunohistochemistry 
revealed that both IL-22R1 and IL-10R2 are expressed at the ocular surface (Fig 3B, C), and 
IL-10R2 was increased in mice with DED compared to healthy control.
IL-22 inhibits the expression of inflammatory cytokines by ocular surface epithelial cells 
under hyperosmolar stress
Because IL-22 expression is increased in LGs in DED, and its receptor is expressed on the 
ocular surface, we next examined the effect of IL-22 on the production of inflammatory 
cytokines by corneal epithelial cells in vitro under desiccating hyperosmolar stress. This 
assay mimics the pathophysiology of desiccating stress-induced ocular surface inflammation 
in DED.24 Primary human corneal epithelial cells (hCECs) were exposed to 380m osmolar 
medium to induce hyperosmolar stress in the presence and absence of IL-22. After 18 hours, 
culture supernatants were collected and ELISA was performed to assess the expression of 
inflammatory cytokines IL-1β, TNF-α, and, IL-8 (Fig 4A), and the Th17-inducer cytokines 
IL-6 and IL-23 (Fig 4B). Hyperosmolar stress induced the secretion of IL-1β, TNF-α, IL-8, 
IL-6 and IL-23 by hCECs, and this induction could be substantially suppressed by IL-22. 
These results indicate that IL-22 exerts anti-inflammatory effects on ocular surface epithelial 
cells.
IL-22 deficiency enhances ocular surface infiltration of IL-17 secreting cells and 
epitheliopathy in dry eye disease
Finally, to determine the function of IL-22 in the pathogenesis of DED in vivo, we created 
IL-22 deficiency either using an IL-22 neutralizing antibody (αIL-22) or IL-22 knock-out 
(KO) mice. αIL-22s were intravenously administered into mice during DED induction. PBS 
injected mice served as controls. Seven days after disease induction, ocular surface tissues 
(cornea and conjunctiva) were harvested to measure the frequencies of IL-17 secreting cells 
using flow cytometry. DED induction resulted in increased infiltration of IL-17 secreting 
cells, which was further augmented in αIL-22 treated mice as compared to PBS control (Fig 
5A). IL-22 function in DED pathogenesis was further confirmed using genetically deficient 
IL-22 KO mice. DED was induced in IL-22 KO and wild type (WT) mice. Then frequencies 
of IL-17 secreting cells on the ocular surface and progression of disease by grading corneal 
epithelial erosions were evaluated. Consistent with blocking IL-22 in vivo, IL-22 KO mice 
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showed significantly enhanced ocular surface infiltration of IL-17 positive cells compared to 
WT mice (Fig 5B). Regarding the cellular origin of increased IL-17 secretion at ocular 
surface in DED mice, flow cytometric analysis of ocular surface tissues revealed increased 
infiltration of CD4+IL-17+ cells (Th17; 14.00 %), but not CD3ε-NK1.1+IL-17+ cells (NK 
cell; 1.67 %) and CD11b+Gr-1+IL-17+ cells (Neutrophils; 1.93%), (Supplement 2). Using 
Immunohistochemistry, effect of IL22 on infiltration of IL-17 secreting CD4 cell was further 
confirmed in IL-22 KO mice after DED induction. Consistent with flow cytometry analysis, 
IL-22 deficiency resulted in increased infiltration of CD4+IL-17+ cells in conjunctival cross 
sections after DED induction (Fig. 5C, white arrows). Moreover, most of CD4+IL-17+ 
primarily infiltrated into conjunctival epithelia (Fig. 5C, green arrows). As IL-6 and IL-23 
are major cytokines that promote Th17 immune response,25–28 we next estimated ocular 
surface levels of IL-6 and IL-23 in WT and IL-22 KO mice after DED induction. ELISA 
analysis on corneoconjunctival lysates showed elevated levels of IL-6 and IL-23 in WT DED 
mice compared to the normal control group. Similar to Th17 frequencies, IL-22 KO mice 
showed a significant 2.5 fold increase in the ocular surface level of IL-6 and IL-23 compared 
to WT after DED induction (Fig. 5D). We next investigated the effect of IL-22 
epitheliopathy by monitoring corneal erosions, which is a pathological characteristic of 
DED, in both WT and IL-22 KO mice. IL-22 KO mice showed a significant 3-fold increase 
of the corneal erosion grade during the early induction phase (day 1 and 3) compared to WT 
mice (Fig. 5E). However, in the later stage of the disease (day 7 onward) the corneal erosion 
scores in IL-22 KO and WT mice were similar. Having shown earlier that non immune 
acinar cells are a major source of IL-22, we next investigated whether IL-22 secretion by 
non-immune acinar cells is critical for the suppression of pathogenic Th17 cell responses 
during DED progression. Bone marrow (BM) chimera experiments were performed where 
WT and IL-22 KO irradiated mice were reconstituted with BM cells of IL-22 KO and WT 
mice, respectively (Fig. 6A). At 7 days post-DED induction, flow cytometry analysis of 
corneoconjunctival cells revealed increased infiltration of ocular surface Th17 cells in the 
IL-22 KO host with WT BM compared to the WT host with IL-22 KO BM (Fig. 6B). 
Consistently, the cornea erosion grades were higher for the IL-22 KO host with WT BM 
than the WT host with IL-22 KO BM during DED (Fig. 6C).
Collectively, these results suggest that non immune cell derived IL-22 is essential for the 
suppression of pathogenic Th17 infiltration after DED induction.
DISCUSSION
This study demonstrates the immunoregulatory function of IL-22 in suppressing IL-17-
mediated ocular mucosal inflammation in DED. Specifically, we show herein that elevated 
secretion of IL-22 by the LG in DED patients negatively correlates with disease severity. 
Acinar cells of the LGs, and not infiltrating immune cells, produce IL-22, which protects 
ocular surface epithelium and inhibits infiltration of Th17 cells to the ocular surface in 
desiccating stress-induced DED.
In the pathogenesis of DED, T cell cytokines, primarily IL-17 initiate the immune response 
and cause inflammation at the ocular surface.6, 11, 29 In addition to IL-17, IL-22 levels have 
also been reported to be increased in many autoimmune disorders.16, 30 We show that LF 
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from DED patients has increased levels of IL-17 and IL-22, two Th17 cytokines which have 
been associated with the pathogenesis of various autoimmune disorders, including Sjögren’s 
syndrome. In accord with previous studies,11, 31 we observed that IL-17 levels positively 
correlate with disease severity. However, our study further shows that IL-22 levels in tears 
inversely correlate with severe disease symptoms, suggesting a protective role of IL-22 in 
the DED. Since LF is diluted with secretions from meibomian glands and 
corneoconjunctival cells while constituting the TF at the ocular surface, we observed a 
moderate increase in IL-22 levels in TF of DED patients compare to healthy controls. IL-22 
has been strongly associated with mucosal immune response due to its secretion by immune 
cells and direct effect on mucosal surface of various organs such as pancreas, liver, kidney, 
and joints.18, 32 Because it is difficult to examine the exact cellular source of IL-22 in human 
subjects, we used a well characterized mouse model of DED to explore the source and 
precise function of IL-22 in the pathogenesis of DED. Multiple reports suggest that IL-22 is 
primarily secreted by Th17, Th22, NK cells, and innate lymphoid cells.15, 33, 34 Our study 
provides novel evidence that non-immune cells such as acinar cells in the LGs secrete IL-22, 
and this secretion is augmented in DED condition. Moreover, results from BM chimera 
experiments suggest protective function of non-immune cells secreting IL-22 in DED (Fig. 
6).
We demonstrate an increased expression of IL-22 receptors (heterodimer of IL-22R1 and 
IL-10R2) by the ocular surface epithelium, indicating the importance of an IL-22 mediated 
signaling cascade in the immunopathogenesis of DED. Expression of IL-22 receptors has 
been shown previously on other non-ocular mucosal surfaces such as lung and intestine.35, 36 
DED is associated with the increased expression of proinflammatory cytokines TNF-α, 
IL-1β, IL-8, and Th17-inducing cytokines IL-6 and IL-23 at the ocular surface.5 Here, we 
show that IL-22 inhibits expression of such inflammatory cytokines and Th17 inducing 
cytokines IL-6 and IL-23 by ocular surface epithelial cells under desiccating (hyperosmotic) 
stress.
Utilizing the loss of function approach, we finally determined the in vivo contribution of 
IL-22 in the pathogenies of DED. We blocked the endogenous IL-22 using a neutralizing 
antibody in a mouse model of DED. Our study shows that in vivo neutralization of IL-22 led 
to increased infiltration of IL-17-secreting cells at the ocular surface under desiccating stress 
suggesting IL-22 is essential for inhibiting Th17-mediated mucosal inflammation in DED. 
We confirmed the effect of IL-22 on Th17 cell infiltration and progression of DED 
pathogenesis using IL-22 KO mice. Consistent with our IL-22 neutralization assay, IL-22 
KO mice with DED showed a profound infiltration of IL-17 positive cells to the ocular 
surface. Based on our previous results showing IL-22 mediated inhibition of expression of 
Th17 inducers IL-6 and IL-23 by ocular surface epithelial cells (Fig. 4B) and their increased 
expression in IL-22 KO mice (Fig. 5D), we hypothesize that IL-22 deficiency promotes 
Th17 cell generation and infiltration in DED mice. In fact, a previous report has suggested 
that IL-22 suppresses the infiltration of Th17 cells in intestinal mucosa and maintains 
mucosal barrier function.25 Furthermore, our data shows that IL-22 mediated suppression of 
pathogenic IL17-secreting cells results in reduced DED, particularly in the early induction 
phase, as demonstrated by high clinical corneal erosion scores in IL-22 KO mice. However, 
similar high corneal erosion scores in the later stage of disease in both IL-22 KO and WT 
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mice suggests that IL-22 might be inefficient in regulating severe IL-17-mediated ocular 
inflammation in chronic or later stage of DED. This could also be due to the low expression 
of IL-22 in severe inflammation similar to our DED severity and IL-22 correlation data (Fig. 
1C) in human.
In summary, these findings provide new insights on both cellular source and function of 
IL-22 in the pathogenesis of DED. Inverse correlation of high levels of IL-22 in human 
tears, and its inhibitory effect on Th17 mediated inflammation in mice indicate that IL-22 
regulates ocular mucosal inflammation in DED. In addition, the demonstration that IL-22 
blockade leads to amplification of Th17 immunity and ocular surface damage suggests its 
potential as a novel treatment approach. Strategies designed to augment IL-22 levels at the 
ocular surface, and thereby suppressing Th17 functionality, may be a viable therapeutic 
approach for DED.
METHODS
Patient enrollment and determination of dry eye disease
The study was approved by the Institutional Review Board and followed the tenets of the 
Declaration of Helsinki, and informed consents were obtained from all patients. A total of 
31 non-Sjögren-type DED patients (11 male, 20 female) with a mean age of 59.3 ± 13.1 
years (range: 35 – 78 years) completed the study. The inclusion criteria were as follows: one 
or more DED-related symptoms, including tightness, foreign body sensation, irritation, red-
eye, itching sensation, blurring, or pain; Schirmer’s test (without anesthesia) of 5 mm in 5 
minutes or less in both eyes; tear break-up time (TBUT) of 5 seconds or less in both eyes; 
typical DED pattern of superficial punctuate erosion of conjunctiva or cornea. The control 
group was composed of 18 healthy, age- and sex-matched subjects (6 male, 12 female) who 
had no history of ocular or systemic disease. The mean age of controls was 57.4 ± 14.1 years 
(range: 39 – 71 years).
For baseline evaluations, the TBUT, Schirmer’s test, fluorescein staining using 
biomicroscopy, tear sampling, and intraocular pressure were assessed on both eyes of DED 
patients and healthy controls. We also obtained symptom severity scores from DED patients 
using the OSDI score. During the data collection period, all evaluations were performed in a 
blinded fashion. DED parameters and tear sampling were performed by H.S.H. and Y.W.J., 
blinded to the patient’s disease status, and collected tears and prepared them for analysis. 
The data were then analyzed by E.J.C. who was also blinded to the patient’s disease status.
Tear collection and measurements of IL-22 and IL-17 levels
To measure the concentration of IL-22 and IL-17 in patients’ tears, a bonded 2.0 × 10 mm 
polyester fiber rods was used to collect total TF from conjunctival sac, as previously 
reported.37, 38 Briefly, a polyester wick was applied to tear meniscus of lower conjunctival 
sac and collected samples were stored at −70°C for mass spectrophotometric analysis. In 
addition to the TF, which is a mixed fluid of the secretion from the LGs, meibomian glands, 
and corneoconjunctival cells, pure LF was collected. The detailed methods for collecting LF 
are shown in Supplement 1 (Supplementary Video file).
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All Nano-liquid chromatography-tandem mass spectrometry (LC-MS/MS) experiments were 
carried out on an Applied Biosystem/MDS Sciex 4000 Qtrap quadrupole mass spectrometer 
(AB/MDS Sciex, Concord, Canada) that was equipped with a turbo-ion spray source. The 
mass spectrometer was coupled with an Agilent 1200 series HPLC system (Agilent 
Technologies, Santa Clara, CA). Data were acquired and processed using Analyst software 
(version 1.4.2, AB/MDS Sciex). The chromatographic separation was achieved with a 
Synergi Hydro-RP (C18) 50 × 2.1 mm I.D., 4 μm 80-Å particles column (Phenomenex, 
Torrance, CA) at 40 °C. The mobile phase was a binary gradient using 40 % acetonitrile as 
solution A and 100 % methanol as solution B. The flow rate was 0.6 ml/min. In addition to 
the IL-22 and IL-17, total protein concentrations in LF (Control: 6.2 ± 3.6 mg/ml; DED: 4.1 
± 3.8 mg/ml, p = 0.033 by Mann-Whitney U test) and TF (Control: 7.9 ± 3.2 mg/ml; DED: 
13.9 ± 5.2 mg/ml, p = 0.029 by Mann-Whitney U test) was also estimated using LC-
MS/MS.
Mouse model of dry eye disease
Six- to 8-week-old male C57BL/6 mice (Charles River Laboratory, Wilmington, MA) and 
IL-22 KO mice (UC Davis MMRRC, Davis, CA) were used in accordance with the 
standards of the Association for Research in Vision and Ophthalmology Statement for the 
Use of Animals in Ophthalmic and Vision Research. The research protocol was approved by 
the Yonsei University College of Medicine. The in vivo mouse experiments were performed 
at the Institute of Vision Research at the Yonsei University College of Medicine. DED was 
induced in mice as described previously.6, 7, 39, 40 In brief, mice were exposed to a controlled 
environment chamber (CEC), which allows the controlled regulation and maintenance of the 
temperature (21 – 23 °C), relative humidity (< 30 %), and airflow (15 L/min). Clinical signs 
such as corneal erosions were assessed by corneal fluorescein staining using 1% fluorescein 
(Sigma-Aldrich, St. Louis, MO) according to the standard National Eye Institute scoring 
system. One week post DED induction, mice were euthanized and tissues were collected for 
immunohistochemistry and molecular studies. For in vivo IL-22 blockade experiments, 100 
μg/mouse of αIL-22 (AF582, R&D Systems, Minneapolis, MN) or PBS were intravenously 
injected into WT mouse at 2-hour before placing them into the CEC and then daily for 3 
days.
Bone marrow chimera experiments
WT B6 and IL-22 KO mice between 6- and 8-week of age were used to make BM chimera. 
At the day of BM transfer, mice were given lethal total body irradiation (950 – 1000 rad) 
from a 137 Cs source. Four hours later, they were reconstituted with WT or IL-22 KO mice 
BM cells (1 × 107) that had been harvested from the femurs of age-matched mice. 
Experimental transfers were as follows: WT BM cells into irradiated IL-22 KO mice (WT 
BM → IL-22 KO host) and IL-22 KO BM cells into irradiated WT mice (IL-22 KO BM → 
WT host). Animals were allowed to reconstitute for 45 days. Before DED induction, only 
healthy mice with no obvious signs of graft-vs-host disease or other illness were used in 
experiments. DED induction, sacrifice, and securement of the tissues were performed as 
described above. At day seven post-DED induction, the cornea and conjunctiva were 
harvested to analyze the infiltration of Th17 cells using flow cytometry.
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Immunohistochemistry
Whole corneas and LGs were fixed in 4 % paraformaldehyde and histological cross sections 
(7 μm thick) were mounted on poly-L-lysine coated slides. Cross sections were then 
deparaffinized and stained with anti mouse primary (IL-22, GTX109659, GeneTex, Zeeland, 
MI; IL-22R1, ab211675, Abcam, Cambridge, UK; IL-10R2, SC-271969, Santa Cruz 
Biotech., Santa Cruz, CA) overnight at 4 °C. Sections were then incubated with peroxidase-
conjugated streptavidin for 20 minutes at room temperature. Protein expression was detected 
using diaminobenzidine chromogen and 0.05 % H2O2 and evaluated under a florescent 
microscope (BX51-FL, Olympus, Tokyo, Japan). The sections were also counterstained with 
Meyer’s hematoxylin (DAKO, Glostrup, Denmark). Human skin and colon tissue were used 
as positive controls (data not shown). Sections were observed under a light microscope 
(Axio Imager 2, Carl Zeiss, Oberkochen, Germany). For, immunofluorescence staining, anti-
mouse IL-17 antibody (ab79056, Abcam), Goat anti-rabbit IgG (ab150077, Abcam), and 
Alexa Fluor 594 conjugated anti mouse CD4 antibody (100446, BioLegend, San Diego, CA) 
were used. The sections were observed with the confocal microscopy (LSM 800, Carl 
Zeiss).
Quantitative PCR
Corneas and LGs were harvested from control and DED mice. RNA was isolated using the 
RNeasy Micro Kit (Qiagen, Valencia, CA) and reversed transcribed into cDNA with 
Superscript III Kit (Invitrogen, Carlsbad, CA). Quantitative PCR was performed using 
SYBR Premix Ex Taq (Takara Bio, Shiga, Japan) with pre formulated primers and 
StepOnePlus Real-Time PCR detection system (Applied Biosystems, Foster City, CA). The 
results were analyzed by the comparative threshold cycle method. GAPDH was used as an 
internal control, and data were normalized to untreated controls.
Human corneal epithelial cell culture and hyperosmotic stimulation
Human corneal limbal tissue was harvested from donor corneal buttons following 
keratoplasty, in accordance with the tenets of the Declaration of Helsinki and with the 
permission of the Institutional Review board. Corneal limbal tissues were prepared and 
cultured as described previously.41, 42 In brief, cells were cultured for a period of 18 hours in 
a hyperosmolar serum-free media (380m osmol; achieved by adding sodium chloride) in the 
presence or absence of murine recombinant IL-22 (BioLegend). The actual osmolality of 
medium was confirmed with an ohmmeter (Model 3320, Advanced instrument, Norwood, 
MA).
Flow cytometry
Single-cell suspensions of harvested corneas were prepared by collagenase digestion and 
blocked with an anti-FcR monoclonal antibody for 30 minutes at 4 °C in 1 % bovine serum 
albumin/0.02 % NaN3/PBS. Isolated cells were stained with fluorochrome conjugated 
antibodies and appropriate isotype controls (BioLegend) for 45 minutes at 4 °C. For 
intracellular staining, cells were first stimulated with Phorbol 12-myristate 13-acetate 
(PMA)/ionomycin (Sigma-Aldrich) for 6 hours in the presence of GolgiStop (BD 
Biosciences, San Jose, CA), and then fixed and permeabilized using Fix/Perm (eBioscience, 
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San Diego, CA). Stained cells were analyzed with a FACSAria™ flow cytometer (BD 
Biosciences).
ELISA
Protein levels of cytokines in mouse LG tissues and in culture supernatant of hCECs were 
quantified using commercially available ELISA kits: human IL-17 and IL-22 (D1700 and 
D2200, respectively; R&D Systems), human IL-1β, IL-6, IL-8, IL-23, TNF-α (437005, 
430505, 431505, 435407, and 430205, respectively; BioLegend) and mouse IL-6, IL-17, 
IL-22 and IL23 (431305, 436205, 436305, and 433704, respectively; BioLegend).
Statistical analysis
Statistical analyses were performed using SPSS for Windows (version 21.0; SPSS Inc., 
Chicago, IL). Testing for the normality of distribution was performed by using the 
Kolmogorov–Smirnov test. For in vivo and in vitro data that was normally distributed, the 
independent t-test was performed to compare the differences between the two groups and 
one-way ANOVA test with Bonferroni correction was used to make comparisons among 
three or more groups. A linear mixed model with Bonferroni correction for repeated 
measures covariance pattern with unstructured covariance within samples was used for 
estimating significant differences between groups over time. As the majority of the clinical 
data including tear cytokine levels did not show a normal distribution, non-parametric tests 
were adopted. Analyses included the frequency for categorical data and the median with 
IQR for continuous data. The Mann-Whitney U test was performed to compare the 
differences between the two groups and the Kruskal-Wallis test with Bonferroni-Dunn’s 
procedure was used to compare the groups for continuous variables. Correlation between 
tear cytokine levels and dry eye symptoms was assessed using Spearman’s correlation test. 
A p value of < 0.05 was considered significant different. Results are presented as mean ± 
standard errors of means (s.e.m).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
IL-22 and IL-17 levels in tears of patients with dry eye disease and healthy controls. 
Lacrimal fluid (LF) from lacrimal glands and total tear fluids (TF) from conjunctival sac 
were collected using polyester wick from dry eye disease (DED) patients (n=31) and healthy 
controls (CTL) (n=18). IL-22 and IL-17 levels in LF and TF were estimated using Nano-
liquid chromatography tandem mass spectrometry. A. IL-22 levels in LF and TF of healthy 
control and DED patients. B. IL-17 levels in LF and TF of healthy controls and DED 
patients. The box plots bind the interquartile range divided by the median and dots indicate 
individual values (p value by Mann-Whitney U test). C. Correlation analysis between ocular 
surface disease index (OSDI) and IL-22 levels in LF and TF of DED patients. D. Correlation 
analysis between OSDI and IL-17 levels in LF and TF of DED patients. Individual points 
and lines represent the observed values and regression lines (r, Spearman correlation 
coefficient, −1 ≤ r ≤ 1; r and p value by Spearman’s correlation test).
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Figure 2. 
Expression of IL-22 in the lacrimal glands of mice. Lacrimal glands (LGs) from control 
(CTL) and dry eye disease (DED) mice were harvested. A. IL-22-mRNA expression in LG 
lysates was quantitated using real-time PCR. B. IL-22 protein concentrations in LG lysates 
was measured by ELISA. C. Representative immunohistochemistry micrographs of LG 
cross sections from two healthy and four DED mice, which were stained for IL-22 (blue 
arrowhead). Black arrows indicate infiltrated immune cells. D. Bar chart showing 
quantitation of IL22 producing cells as IL22+ cell /High Power Field (HPF). Data shown are 
means (bars) ± s.e.m (error bars) of three independent experiments (n = 5 mice/group; **, p 
< 0.001 by independent t-test).
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Figure 3. 
Expression of IL-22 receptors on the ocular surface of mice. Corneas and conjunctivae from 
healthy (CTL) and dry eye disease (DED) mice were harvested 7 days after DED induction. 
A. IL-22R1 and IL-10R2 transcripts levels were determined using real-time PCR. B. 
Immunohistochemistry micrographs of corneal cross sections showing expression of 
IL-22R1 (black arrows) and IL-10R2 (arrowheads) by corneal epithelial cells. C. 
Representative flow cytometry analysis of corneal and conjunctival single cell suspension 
showing expression of IL-22R1 and IL-10R2. The values shown are means (bars) ± s.e.m 
(error bars) of three independent experiments (n = 5 mice/group; **, p < 0.001 by 
independent t-test; NS, not significant).
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Figure 4. 
Effect of IL-22 on human corneal epithelial cell response to desiccating hyperosmolar stress. 
Human corneal epithelial cells (hCECs) were cultured in 380m osmolar medium for 18 
hours in the presence and absence of IL-22 (30 ng/ml). Culture supernatants were collected 
and ELISA was performed on the inflammatory cytokines IL-1β, TNF α, and IL-8 (A), as 
well as the Th17 inducer cytokines IL-6 and IL-23 (B). Results are expressed as means ± 
s.e.m (error bars) of two independent experiments (n = 8). Dots indicate individual values (*, 
p < 0.01 and **, p < 0.001 by one way ANOVA test with Bonferroni correction; NS, not 
significant)
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Figure 5. 
Effect of IL-22 deficiency on IL-17+ cell infiltration and epitheliopathy in mice with dry eye 
disease. A. IL-22 neutralizing antibodies or PBS were intraperitoneally injected into wild 
type (WT) mice with dry eye disease (DED) and analyzed on day 7. Naïve mice served as 
healthy controls (CTL). Single cell suspension of cornea and conjunctiva were stained with 
anti-IL-17 antibodies and flow cytometry was performed. B. Corneas and conjunctivae were 
harvested from WT and IL-22 knockout (KO) mice with DED, and IL-17+ cell frequencies 
(%) were analyzed using flow cytometry. The data shown are means (bars) ± s.e.m (error 
bars) of three independent experiments (n = 5 mice/group; *, p < 0.01 and **, p < 0.001 by 
one way ANOVA test with Bonferroni correction). C. Representative confocal micrographs 
of conjunctiva showing co-localization of CD4+ (red) and IL-17+ (green) cells (white arrow) 
and infiltration of these cells into conjunctival epithelia (green arrows) at seven-day post 
DED induction. D. ELISA assay for IL-6 and IL-23 concentration from corneoconjunctival 
tissue at 7 days after DED induction. The results shown are means (bars) ± s.e.m (error bars) 
of three independent experiments (n = 4 mice/group; **, p < 0.001 by by one way ANOVA 
test with Bonferroni correction). E. Representative images of fluorescein stained ocular 
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surface and corneal erosion grade of WT (empty circle) and IL-22 KO (filled circle) after 
DED induction. Results are expressed as means (individual points) ± s.e.m (error bars) of 
three independent experiments (n = 4 mice/group; *, p < 0.01 and **, p < 0.001 by a linear 
mixed model with Bonferroni correction).
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Figure 6. 
Non-immune cell-derived IL-22 prevents ocular surface infiltration of pathogenic Th17 cells 
during dry eye disease. A. Schematic illustration of bone marrow (BM) chimera 
experiments. B. Representative histograms showing the frequencies of IL-17 secreting cell 
(Gated within CD4+ cell) at the ocular surface of wild type (WT) host with IL-22 knockout 
(KO) BM (Blue) and IL-22 KO host with WT BM (Red) after dry eye disease (DED) 
induction. C. Representative images of fluorescein stained ocular surface of BM chimeras 
after DED induction. The values shown are means (bars) ± s.e.m (error bars) of two 
independent experiments (n = 4 mice/group; *, p < 0.01 and **, p < 0.001 by independent t-
test).
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